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Background: Government interventions are critical to addressing the global tobacco epidemic, a major public
health problem that continues to deepen. We systematically synthesize research evidence on the effectiveness
of government tobacco control policies promoted by the Framework Convention on Tobacco Control (FCTC),
supporting the implementation of this international treaty on the tenth anniversary of it entering into force.
Methods: An overview of systematic reviews was prepared through systematic searches of five electronic
databases, published up to March 2014. Additional reviews were retrieved from monthly updates until August
2014, consultations with tobacco control experts and a targeted search for reviews on mass media interventions.
Reviews were assessed according to predefined inclusion criteria, and ratings of methodological quality were
either extracted from source databases or independently scored.
Results: Of 612 reviews retrieved, 45 reviews met the inclusion criteria and 14 more were identified from
monthly updates, expert consultations and a targeted search, resulting in 59 included reviews summarizing over
1150 primary studies. The 38 strong and moderate quality reviews published since 2000 were prioritized in the
qualitative synthesis. Protecting people from tobacco smoke was the most strongly supported government
intervention, with smoke-free policies associated with decreased smoking behaviour, secondhand smoke
exposure and adverse health outcomes. Raising taxes on tobacco products also consistently demonstrated
reductions in smoking behaviour. Tobacco product packaging interventions and anti-tobacco mass media
campaigns may decrease smoking behaviour, with the latter likely an important part of larger multicomponent
programs. Financial interventions for smoking cessation are most effective when targeted at smokers to reduce
the cost of cessation products, but incentivizing quitting may be effective as well. Although the findings for bans
on tobacco advertising were inconclusive, other evidence suggests they remain an important intervention.
Conclusion: When designing and implementing tobacco control programs, governments should prioritize
smoking bans and price increases of tobacco products followed by other interventions. Additional studies are
needed on the various factors that can influence a policy’s effectiveness and feasibility such as cost, local
context, political barriers and implementation strategies.* Correspondence: tancy3@mcmaster.ca
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The global tobacco epidemic is a major public health
problem that continues to deepen, with nearly 1 billion
smokers worldwide in 2012 [1]. It is the leading cause
of preventable death, resulting in approximately 6 mil-
lion unnecessary deaths per year [2, 3]. Cigarettes will
kill half their current users through conditions such as
cardiovascular disease, respiratory conditions and can-
cers, and mortality from smoking is expected to in-
crease to an estimated 8 million people per year by
2030 [3]. Secondhand smoke (SHS) is a significant con-
cern as well: more than 600,000 of the total annual
deaths from smoking are due to SHS exposure [2].
The year 2015 marks the tenth anniversary since the
World Health Organization (WHO) Framework
Convention on Tobacco Control (FCTC) came into
force, the first international treaty specially adopted
through WHO. This instrument aims to reduce to-
bacco consumption and protect all people from to-
bacco exposure through provisions that direct
countries to implement tobacco control programs [4].
To guide countries in this process, WHO introduced
the six MPOWER measures (Table 1), each of which
corresponds to one or more FCTC provisions [5]. The
180 parties to the FCTC (as of May 2015) are all man-
dated to take action [6]. However, the bi-annual re-
ports that ratifying countries must submit show
uneven progress [7].
The aim of this systematic overview of systematic re-
views is to take stock of the global research evidence
base in this decennial year about the likely health ef-
fects of different government tobacco control policies.
This provides policymakers with an evidence-based re-
source to help with policy deliberations and decision-
making on setting priorities for national FCTCTable 1 MPOWER measures
MPOWER measure
Monitor tobacco use and prevention policies
Protect people from tobacco smoke
Offer help to quit tobacco use
Warn about the dangers of tobacco
Enforce bans on tobacco advertising and sponsorship
Raise taxes on tobaccoimplementation [8]. Systematic reviews aim to iden-
tify, assess and synthesize all available primary evi-
dence on a research question, and use an objective,
optimized and structured methodology to maximize
transparency and minimize bias. Overviews of system-
atic reviews build on the strengths of individual re-
views and add breadth by integrating the findings of
many reviews together.
Methods
Relevant systematic reviews were identified through sys-
tematic searches of the electronic databases Health
Evidence for research on public health and health pro-
motion, Health Systems Evidence for research on health
systems, Rx for Change for research on behaviour-
change interventions, Cochrane Database of Systematic
Reviews for research on healthcare and health policy,
and Database of Abstracts of Reviews of Effects for re-
search on healthcare and health services delivery, pub-
lished up to March 2014. These databases are
continuously updated and together represent the leading
repositories of health-related systematic reviews. For
Health Evidence, the search term “tobacco use” was en-
tered; for other databases, “tobacco” was entered. This
search strategy was designed to be very broad and cap-
ture as many systematic reviews related to tobacco use
as possible. Relevant reviews in monthly updates from
Health Evidence, Health Systems Evidence and the
Quebec Public Health Research Network were included
as well up to August 2014. Two tobacco control experts
known to the authors were also consulted to identify any
reviews missed by the systematic searches. An additional
targeted search for systematic reviews on mass media
campaigns was conducted in May 2015 in response to
peer review feedback.Description
Surveillance of the prevalence, determinants and impacts of
tobacco use, and measuring the effects of tobacco
control interventions (FCTC Article 20)
Reduce secondhand smoke exposure through comprehensive
smoke-free legislation in public spaces, including all
indoor workplaces (FCTC Article 8)
Cessation support through advice from healthcare providers,
telephone quit lines and easily-accessible or low cost
medications (FCTC Article 14)
Warnings on tobacco packaging and anti-tobacco media
campaigns to promote awareness on the health consequences
of smoking (FCTC Article 11 and Article 12)
Bans on direct (e.g., television advertisements, billboards) and
indirect (e.g., industry-sponsored events) marketing of tobacco
products (FCTC Article 13)
Increasing the price of tobacco products through taxation
(FCTC Article 6)
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evaluating government tobacco control policies. Reviews
that did not follow a systematic methodology and other
overviews of systematic reviews were not included; the
latter’s references were scanned to identify reviews for
inclusion. The MPOWER components were used as an
organizing framework to classify the interventions.
Clinical interventions, such as pharmacologic therapy
and counselling services, were not included. Reviews on
multicomponent programs were excluded if the effects
of individual interventions were not independently stud-
ied or could not be differentiated. Outcome measures re-
lating to tobacco use, SHS exposure and primary health
outcomes were considered. Tobacco use outcomes in-
clude smoking prevalence, quantity of cigarettes con-
sumed, smoking cessation and smoking initiation. SHS
exposure outcomes include both self-reported and
biomarker-validated measures of exposure. Health out-
comes include hospital admissions and risk of any ad-
verse medical event. Measures that did not directly
assess change in smokers, such as recall of media cam-
paigns and perceptions of smoking, were not included.
Reviews were not excluded on the basis of language.
Titles and abstracts were assessed to identify reviews
for inclusion. The full texts were then read to confirm
inclusion. The following data from selected studies were
abstracted into a summary table: number of studies in-
cluded, year of last search and key findings. The quality
ratings given to each review by their source databases
were extracted as well. Health Evidence uses an inde-
pendent quality assessment tool specific for public
health intervention literature [9]. Total scores can range
from 0 to 10, based on which a quality rating is assigned:
“strong” (8 to 10), “moderate” (5 to 7) or “weak” (4 or
less). Health Systems Evidence and Rx for Change use
the AMSTAR tool, which evaluates the quality of sys-
tematic reviews and meta-analyses by 11 quality criteria
[10–12]. Reviews with scores from 9 to 11 are rated as
“high,” from 5 to 8 as “medium,” and from 0 to 4 as
“low.” For this overview, the “strong,” “moderate” and
“weak” terminology was used for AMSTAR to maintain
consistency with Health Evidence. Cochrane Database of
Systematic Reviews does not provide ratings and Data-
base of Abstracts of Reviews of Effects offers a descriptive
quality assessment [13]. A quality assessment was inde-
pendently performed using the AMSTAR tool for re-
views without a numerical quality rating. Strong and
moderate quality reviews published since 2000 were pri-
oritized in the qualitative synthesis.
Results
Six hundred and twelve reviews were identified through
the search strategy. Screening titles and abstracts yielded
67 reviews that possibly met the inclusion criteria. Tworeviewers screened the full-text of reviews and confirmed
45 met the inclusion criteria. Any conflicts were resolved
by discussion between the two reviewers and a third re-
viewer was consulted when required. Four additional re-
views for inclusion were identified from monthly updates,
nine were identified by tobacco control experts and one
was identified from the targeted search for reviews on
mass media campaigns. In total, 59 reviews were included
that together summarized over 1150 primary studies (see
Fig. 1) [14–72].1 The 22 reviews excluded after full-text
screening either evaluated excluded outcome measures
(n = 1) [73], were overviews of systematic reviews (n = 3)
[74–76], did not follow a systematic methodology (n = 1)
[77], only reported results of multicomponent programs
(n = 4) [78–81], did not adequately describe what inter-
ventions were evaluated (n = 2) [82, 83], or were not rele-
vant for assessing government tobacco control policies
(n = 11) [84–94]. Findings from the 38 reviews that were
either strong or moderate quality and published since
2000 are presented here (see Fig. 2) [14–51]. A Web
Appendix contains individualized summaries of these
reviews as well as the lower quality and older reviews (see
Additional file 1) [52–72].
Protect people from tobacco smoke
Twelve reviews summarize the health-related effects of
smoking bans and restrictions in public spaces, workplaces
or residences. Three are strong in quality [14–16], eight
are moderate [17–24] and one is rated as moderate by HE
and as strong by HSE [25]. Overall, most of the eight re-
views on smoking behaviour reported reductions in smok-
ing prevalence and cigarette consumption and increases in
smoking cessation [14, 15, 17–19, 21, 24, 25]. Hopkins
et al. found that workplace smoke-free policies lead to an
absolute reduction in smoking prevalence of 3.4 % (inter-
quartile range (IQR) = −6.3 to −1.4), reduced cigarette
consumption by 2.2 cigarettes per day (IQR = −1.7 to
−3.3), increased quit attempts by 4.1 % (IQR = −0.7 to 6.8)
and increased successful cessation by 6.4 % (IQR = 2.0 to
9.7) [15]. Three reviews found inconsistent evidence for
smoking prevalence or cessation, but reported improve-
ments in other smoking behaviour outcomes [14, 18, 21].
Thomas et al. looked at the effect of smoking bans on so-
cial inequalities in smoking [19] and Kohler and Minkner
reviewed the conditions under which state smoking bans
are effective [24], but neither assessed their overall efficacy.
Three reviews investigating SHS all reported reductions in
SHS exposure with smoke-free policies, in both adults and
children and across various settings including workplaces,
public spaces and hospitality establishments [14, 21, 25].
Similarly, all six reviews investigating primary health out-
comes found decreases in adverse events [16, 20–23, 25].
Tan and Glantz looked at hospital admissions data and
found a reduced risk of admission for coronary
Fig. 1 Process of review selection
Hoffman and Tan BMC Public Health  (2015) 15:744 Page 4 of 11events (relative risk (RR) = 0.85, 95 % confidence interval
(CI) = 0.82 to 0.88), other heart diseases (RR = 0.61, 95 %
CI = 0.44 to 0.85), cerebrovascular accidents (RR = 0.81,
95 % CI = 0.70 to 0.94) and respiratory diseases (RR = 0.76,
95 % CI = 0.68 to 0.85) with smoke-free policies [22]. The
reductions were greatest with comprehensive policies that
banned smoking in workplaces, restaurants and bars.
Therefore, there is very strong evidence that smoke-free le-
gislation reduces smoking behaviour, exposure to SHS and
adverse health outcomes.
Offer help to quit tobacco use
Twelve reviews present research evidence on the effect
of financial assistance or incentives for smokers to quit
smoking and for healthcare professionals to provide
smoking cessation interventions.2 Eight are strong in
quality [14, 26–32] and four are moderate [33–36].
Financial interventions appear to have different effects
depending on whether they are incentives to quit smok-
ing or assistance to lower the cost of cessation therapies,
and whether they target smokers or healthcare pro-
viders. Two reviews investigated smoker-directed finan-
cial assistance and found increased uptake of cessation
therapies and greater levels of smoking cessation[14, 28]. The effect of incentives and competitions for
smokers is less clear, with four reviews reporting in-
creased cessation [30–32, 35] and four reviews finding
an unclear or no effect [26, 27, 29, 33]. Giles et al. [31]
and Cahill and Lancaster [32] found that smokers of-
fered incentives were 2.48 times (95 % CI = 1.77 to 3.46)
and 1.60 times (95 % CI = 1.12 to 2.30) more likely to
quit smoking, respectively. In pregnant women, Likis
et al. reported that financial incentives increased smok-
ing cessation and were the most important component
of multicomponent programs that promote cessation
[30]. Conversely, Cahill and Perera found no effect of in-
centives on long-term quit rates [27], and a separate re-
view by the same authors estimated that community
“quit-and-win” contests lead to fewer than one in 500
smokers quitting smoking [26]. The three reviews that
looked at provider-directed financial interventions found
no effect on smoking abstinence and prevalence in pa-
tients [28, 34, 36]. Financial interventions may thus be
more effective for smoking cessation when they are tar-
geted to make cessation therapies more affordable, but
incentivizing quitting may be effective as well. They do
not appear to influence smoking behaviour when di-
rected at healthcare professionals.
Fig. 2 (See legend on next page.)
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Fig. 2 Overview of results from strong and moderate quality systematic reviews published since 2000. A green square indicates the review found
the intervention had a beneficial effect on the outcome measure. A yellow square indicates the review found an unclear or conditional effect.
A red square indicates the review found the intervention had no effect. Thomas et al. 2008 could not be included in this table under “Protect
people from tobacco smoke” since it looked at the effect of smoking bans on social inequalities in smoking; it did not evaluate their overall
impact or the conditions under which they are effective. Kohler & Minkner 2014 conducted a review of state smoke-free laws and petitions,
initiatives and referendums to protect non-smokers in Germany, finding 56 laws and amendments and 15 initiatives. HE = Health Evidence;
HSE = Health Systems Evidence; RC = Rx for Change
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Three reviews contained evidence on the effects of
health warning labels or plain packaging on tobacco
products. All three are moderate in quality [19, 21, 37].
Two reviews found health warning labels decrease smok-
ing behaviour, reporting reductions in tobacco use and
increases in motivation to quit, quitting likelihood and
likelihood of abstinence after quitting [21, 37]. Thomas
et al. found no effect [19]. Among seven reviews asses-
sing mass media campaigns, four are strong in quality
[14, 38–40] and three are moderate [21, 41, 42]. Five re-
views looked at media campaigns as part of comprehen-
sive tobacco control programs and four reported
reductions in smoking behaviour [14, 21, 38, 41]. Bala
et al. showed inconsistent effects and raised concerns
about the quality of the evidence [40]. An update to this
review found strong evidence that mass media cam-
paigns, within the context of multicomponent programs,
promote cessation and reduce smoking prevalence [41].
This updated review identified several features of effect-
ive campaigns: wide population reach, high intensity,
long duration, use of television and messages on the
negative health effects of smoking [41]. The remaining
systematic reviews focused on mass media campaigns in
subpopulations. Guillaumier et al. found insufficient evi-
dence for their effect on smokers of low socioeconomic
status [42], while Brinn et al. [39] reported inconsistent
evidence for their effect on young people. Therefore, the
evidence suggests that interventions cautioning people
about tobacco’s harms may be effective strategies, with
mass media campaigns being potentially important parts
of multicomponent programs.Enforce bans on tobacco advertising, promotion
and sponsorship
Four reviews present research evidence on the health-
related effects of tobacco advertising bans and restric-
tions, all of which are moderate in quality [19, 21, 43, 44].
None of the reviews found clear reductions in smoking
behaviour, with Quentin et al. reporting inconsistent ef-
fects [43] and Capella et al. showing no reduction in
cigarette consumption [44]. Although Mozaffarian et al.
did not report any direct effects, this review postulated
that advertising restrictions should decrease smokingbehaviour based on the well-established association be-
tween advertisements and tobacco use [21]. Indeed, indi-
vidual studies have demonstrated that tobacco marketing
and cigarette use in movies alter adolescents’ attitudes
and susceptibilities to smoking, which in turn places them
at risk of initiating cigarette use and continuing this be-
haviour into adulthood [95–99]. Although systematic re-
views have not conclusively shown that banning tobacco
marketing is an effective tobacco control measure, sub-
stantial evidence exists on the harmful consequences of
unregulated advertising on smoking behaviour.
In addition, there are individual studies that support
the effectiveness of these interventions. Saffer and
Chaloupka looked at 22 OECD countries and showed
that comprehensive advertising bans reduce tobacco con-
sumption, but that limited advertising bans—where other
avenues of promotion are still available to companies—do
not reduce tobacco consumption [100]. An analogous
study by Blecher that included the OECD countries as
well as 30 developing countries had similar findings
[101]. A sub-analysis of the developing countries showed
that both comprehensive and limited bans reduced smok-
ing in these countries, with comprehensive bans having
greater effects [101]. The scope of advertising restrictions
and how they are enforced may therefore be critical fac-
tors in their effectiveness.
Raise taxes on tobacco
Among the six reviews evaluating tobacco price in-
creases, one is high in quality [14] and five are moderate
[19, 21, 45–47]. All but one of the reviews found that in-
creasing the price of tobacco reduces smoking behaviour,
with decreases in cigarette consumption and smoking
prevalence and increases in smoking cessation. Hopkins
et al. combined seven studies that estimated price elasti-
cities of demand and found that every 10 % increase in
cigarette prices decreased smoking prevalence and
cigarette consumption by 3.7 and 2.3 %, respectively
[14]. Price increases appear to be most effective among
adolescents, young adults and persons of low socioeco-
nomic status [19, 45, 46]. Rice et al. reported negative
price elasticities for smoking participation, prevalence,
consumption and initiation, and greater smoking cessation
in youths with price increases [46]. However, Guindon
found inconclusive results on the effect of tobacco price
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indicates increasing the price of tobacco products is a very
important intervention for tobacco control.
Restrict sales to minors
Five reviews summarize the health-related effects of
restricting youth access to tobacco products, all of which
are moderate in quality [19, 48–51]. This intervention is
not part of MPOWER but is promoted in the FCTC
under Article 16 (“prohibiting sales to and by minors”).
Across the systematic reviews there was no consistent
effect found for youth access interventions on smoking
behaviour. Fichtenberg and Glantz showed that such re-
strictions do not reduce smoking prevalence among
teens, even with high compliance among cigarette mer-
chants [48]. However, DiFranza reported that banning
the sale of tobacco products to minors is effective in de-
creasing youth smoking, but only if the restrictions are
strongly enforced [51]. The three remaining reviews found
inconsistent evidence [19, 49, 50]. The literature on youth
access interventions is thus inconclusive; restrictions, if
they are effective, appear to depend on robust enforcement.
Discussion
Principal findings
This systematic overview of systematic reviews summa-
rizes the research evidence on the likely health-related
effects of government tobacco control policies promoted
in the FCTC, identifying gaps in the literature and pro-
viding a framework for policy deliberations and future
research. It includes 59 systematic reviews, encompass-
ing more than 1150 individual studies.
Among the government tobacco control policies identi-
fied, protecting people from tobacco smoke through smok-
ing bans and price increases of tobacco products have the
strongest evidence of effectiveness. Smoke-free policies
were consistently associated with reductions in smoking be-
haviour, SHS exposure and adverse health outcomes. Their
success has been demonstrated in diverse settings. Robust
evidence was similarly found for raising tobacco prices,
such as through taxation, with decreases in smoking behav-
iour found by five reviews. The cumulative evidence from
this overview suggests that smoke-free policies and tobacco
taxation may be the two most important interventions pro-
moted by the FCTC and should be prioritized by govern-
ments when developing their tobacco control programs.
Positive results were also found for warning people
about the dangers of tobacco through mass media cam-
paigns and cigarette packaging interventions, with the
former likely being integral parts of multicomponent
programs. Financial assistance reducing the costs of
smoking cessation interventions and financial incentives
may be effective strategies; the effect of provider-
directed interventions is less clear. Limited evidence wasfound for advertising restrictions, but evidence on how
advertisements influence smoking behaviour, the sub-
stantial investments that cigarette companies have made
to promote their products and individual studies demon-
strating their effectiveness all suggest these interventions
remain important. No reviews were identified for moni-
toring tobacco use and prevention policies, indicating a
need for research syntheses on their effectiveness.
Although this overview assesses the effectiveness of in-
dividual government tobacco control policies, countries
should implement comprehensive programs that contain
two or more FCTC provisions and that are tailored spe-
cifically to their national situations. Such multicomponent
programs are the most effective approach to tobacco con-
trol, with policies acting synergistically when enacted to-
gether [102, 103]. While greater research evidence exists
for certain interventions, all tobacco control measures
under the FCTC are important and should ideally be im-
plemented concurrently. However, it is often not possible
for countries to dedicate equal resources to each policy or
to introduce them simultaneously. The 2014 Global Pro-
gress Report showed variability in implementation rates
across FCTC provisions, with over 90 % of parties report-
ing to have prioritized one or more areas of the treaty
over others [104]. Lack of financial, human, research and
political resources were also identified as barriers to full
implementation [104]. Thus, while countries would
ideally implement all tobacco control policies concur-
rently, regulations that ban smoking and increase tobacco
product prices should be prioritized in situations where
resources are constrained. The other FCTC provisions
can then further strengthen and work synergistically with
these priority policies. This will help promote an evidence-
based prioritization of policies and maximize the likeli-
hood that limited resources will be allocated to those
measures most likely to protect people from the harm-
ful effects of tobacco.
Strengths and limitations
This overview has several methodological strengths. First,
prioritizing systematic reviews allowed a huge body of re-
search evidence to be synthesized—over 1150 studies—cov-
ering a wide variety of interventions, outcomes, conditions
and populations in a single analysis. Second, a systematic
and transparent search protocol was implemented, minim-
izing bias while ensuring that as many systematic reviews
evaluating government tobacco control policies as possible
were identified and assessed for inclusion. Third, the quality
of each systematic review was considered, with quality rat-
ings either extracted from source databases or independ-
ently scored. These quality ratings were then used, along
with the date of publication, to prioritize included reviews,
maximizing confidence in the resulting analyses as a good
starting point for decision-making.
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searches were restricted to the five leading databases of
systematic reviews; unpublished reviews will have been
missed. Furthermore, many disciplines have different ap-
proaches to literature reviews that place less emphasis
on describing the search strategy and inclusion/exclu-
sion criteria. As such, some excellent comprehensive re-
views may have been excluded by the databases or have
low quality ratings [67, 103, 105]. Second, the intricacies
and details of each individual study are invariably lost
when integrating findings from over 1150 primary
sources. Third, evaluations of multicomponent policies
were excluded, limiting this overview to summarizing
the impact of interventions when used in isolation.Future directions
Based on the cumulative evidence, the effectiveness of
smoke-free policies is well established; the current evi-
dence demonstrates smoke-free policies are critical to-
bacco control interventions. Tobacco price increases are
also well supported by the literature, although future
studies and reviews could helpfully assess outcomes
other than smoking behaviour. More evaluations of the
remaining interventions are important to determine
their overall effectiveness and the conditions under
which they are most impactful. For all interventions,
studies and syntheses of the various factors that can in-
fluence their effectiveness and feasibility, such as cost,
local context, political barriers and implementation
strategies, are needed. The differential effect of these
policies, such as by a nation’s level of development or by
a population’s demographic characteristics, is also an im-
portant research gap. Studies and syntheses evaluating
the synergistic effects of multicomponent programs and
determining which combinations of policies are most ef-
fective would be particularly beneficial for governments
in establishing or expanding evidence-based tobacco
control programs. Research should also not be limited to
the FCTC provisions; innovative and radical approaches,
or “endgame proposals,” should be encouraged to fur-
ther reduce and ultimately eliminate tobacco use [106].
Conclusion
This overview of systematic reviews provides a summary
of current research evidence on the effectiveness of indi-
vidual government tobacco control policies. The 180 state
parties to the FCTC and other countries can use this work
as a resource for policy decisions on prioritizing, designing
and implementing their tobacco control programs. Based
on this overview, governments should focus their efforts
on enacting smoke-free legislation and taxing tobacco
products. Other tobacco control policies should then beconsidered to build on their effectiveness and establish
comprehensive programs.Endnotes
1The exact number of primary studies could not be cal-
culated because some reviews did not report the number
of studies they summarized. The estimate of 1150 pri-
mary studies is conservative.
2Evidence from systematic reviews on the effects of pro-
viding telephone counselling and cessation advice from
healthcare workers was not included due to the clinical
context in which these interventions were implemented.
This overview focuses on evidence from evaluations of
government tobacco control policies.Additional file
Additional file 1: Summary of key findings from 59 systematic
reviews.
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